Literature DB >> 8313418

Endothelin receptors in cultured adult rat cardiac fibroblasts.

L C Katwa1, E Guarda, K T Weber.   

Abstract

OBJECTIVES: Endothelins, released by vascular endothelial cells, are known growth promoters of various mesenchymal cells that contribute to stromal protein accumulation. Whether endothelins could contribute to myocardial fibrosis depends, in part on whether cardiac fibroblasts have endothelin receptors. The identification and binding characteristics of endothelin-1 and endothelin-3 and their ETA and ETB receptor subtypes in cultured adult rat cardiac fibroblasts represented study objectives.
METHODS: Cultured rat cardiac fibroblasts (passages 5-10) grown until confluence were used to study radioligand binding assays, receptor subtypes, association and dissociation, effects of agonist and antagonist on binding kinetics, and affinity cross linking.
RESULTS: Binding association of 125I-endothelin-1 and 125I-endothelin-3 was rapid, specific, and saturable within 60 minutes. The dissociation of receptor bound 125I-endothelin-1 was slow and partially reversible (30%-40%), suggesting more than one class of endothelin receptors, whereas the dissociation of 125I-endothelin-3 was time dependent and reversible. Competitive displacement with unlabeled endothelin-1, endothelin-3, endothelin-receptor nonselective sarafotoxin (S6b), and ETA receptor selective antagonist PED-3512-PI were used to identify receptor subtypes. Displacement of 125I-endothelin-1 by cold endothelin-1, resulted in a low affinity, high binding site (IC50 5.4 x 10(-9) M; 3.6 x 10(4) binding sites.cell-1) and a high affinity, low binding site (IC50 4.2 x 10(-4) M; 11,830 binding sites.cell-1). With 125I-endothelin-1 the IC50 s for sarafotoxin, endothelin-3, and PED-3512-PI were 1.8 x 10(-10), 1.7 x 10(-9), and 3.7 x 10(-9) M, respectively; for 125I-endothelin-3 these IC50s were 2.28 x 10(-11), 1.9 x 10(-10), and 1.7 x 10(-9) M, respectively. Endothelin receptor subunits of 53, 37, 34, and 24 kDa were identified by affinity cross linking.
CONCLUSION: Endothelin-1 and endothelin-3 binding and ETA and ETB receptor subtypes are present in cardiac fibroblasts with ETB predominant. The presence of these receptors support the hypothesis that endothelins may regulate cardiac fibroblast function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8313418     DOI: 10.1093/cvr/27.12.2125

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  17 in total

Review 1.  Bosentan and the endothelin system in congestive heart failure.

Authors:  S H Ellahham; V Charlon; Z Abassi; K A Calis; W K Choucair
Journal:  Clin Cardiol       Date:  2000-11       Impact factor: 2.882

Review 2.  Hemodynamic effects of bosentan in patients with chronic heart failure.

Authors:  W Kiowski; G Sütsch; E Oechslin; O Bertel
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 3.  Pleiotropic effects of cardiac drugs on healing post-MI. The good, bad, and ugly.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2008-02-07       Impact factor: 4.214

4.  Gq-activated fibroblasts induce cardiomyocyte action potential prolongation and automaticity in a three-dimensional microtissue environment.

Authors:  C M Kofron; T Y Kim; M E King; A Xie; F Feng; E Park; Z Qu; B-R Choi; U Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-07-14       Impact factor: 4.733

5.  Pro-remodeling peptides modulate collagen α1(I) promoter activity in rat cardiac myofibroblasts.

Authors:  Andrew Kisling; Laxmansa C Katwa
Journal:  Biochem Biophys Res Commun       Date:  2019-06-08       Impact factor: 3.575

6.  Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo.

Authors:  Laxmansa C Katwa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-05-08       Impact factor: 4.733

Review 7.  Endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Chao Liu; Junmin Chen; Yanqiu Gao; Bao Deng; Kunshen Liu
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 8.  The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Kevin K Brown
Journal:  BioDrugs       Date:  2010-02-01       Impact factor: 5.807

9.  Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.

Authors:  M G Peter; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

10.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.